MAPT and Alzheimer disease: A rationale often proposed to account for the increased cortical excitability in MCI and AD patients in the first stages of disease postulates that it represents a compensatory mechanism to counteract synaptic dysfunction and tau NFT accumulation within neuronal networks (9).